Semiquantitative Assessment of Iodine Extravasation in Acute Ischemic Stroke After Mechanical Thrombectomy

Semiquantitative Assessment of Iodine Extravasation in Acute Ischemic Stroke After Mechanical Thrombectomy

Mechanical thrombectomy is a life-saving treatment for acute ischemic stroke caused by large artery occlusion—restoring blood flow to the brain can mean the difference between disability and recovery. But it carries a hidden risk: iodine extravasation, when the iodine-based contrast dye used during the procedure leaks into brain tissue. This leakage isn’t just a technicality—it may signal dangerous hemorrhagic transformation (bleeding in the brain) that can worsen outcomes. Until now, doctors lacked simple, reliable ways to measure this leakage and predict who’s at risk.

Researchers from the People’s Hospital of Deyang City in Sichuan, China, set out to change that. In a 2021 study, they tested two easy-to-use “semiquantitative” methods to assess iodine extravasation and link it to bleeding risk in stroke patients who’d undergone successful thrombectomy.

How the Study Worked

The team enrolled 93 consecutive patients with anterior circulation strokes (blockages in the brain’s front arteries) who met strict criteria: stroke onset within 6 hours, age 18+, a NIHSS (stroke severity) score ≥6, an ASPECTS (CT-based brain damage) score ≥6, and no pre-existing bleeding. After excluding patients with prior strokes, failed thrombectomy, or missing images, 72 patients remained—29 who developed bleeding (HT group) and 43 who didn’t (non-HT group).

All patients got a dual-energy CT scan right after thrombectomy. This advanced scan creates three key images:

  1. Virtual non-contrast (VNC): Rules out pre-existing bleeding.
  2. Iodine overlay map (IOM): Highlights where iodine has leaked.
  3. Reconstructed 120 kV CT: A “simulated” conventional CT for easy reading.

The team used two methods to measure iodine leakage:

  1. Modified ASPECTS (mASPECTS): Instead of scoring low-density brain damage (like the original ASPECTS), they scored high-density areas (iodine leakage) on the simulated CT. A score of 10 meant no leakage; 0 meant widespread high density.
  2. Dense Iodine Extravasation: A simple yes/no rating (0 = no dense leakage, 1 = yes). “Dense” leakage was defined as involving at least two ASPECTS regions with no normal brain tissue visible in those areas (after adjusting CT settings).

Two radiologists independently scored the images. They used weighted Kappa statistics to check agreement—scores above 0.8 mean “excellent,” 0.6–0.8 mean “good.”

What They Found

First, the methods were reliable:

  • mASPECTS had good interobserver agreement (Kappa = 0.80).
  • Dense iodine extravasation had excellent agreement (Kappa = 0.85).

Next, the results clearly linked leakage to bleeding:

  • Patients in the HT group had much lower mASPECTS scores (average 5 vs. 9 in the non-HT group) and were 7x more likely to have dense leakage (87.5% vs. 11.6% in non-HT).
  • In multivariate analysis (after adjusting for age, gender, and other factors), dense iodine extravasation was the strongest predictor of bleeding (odds ratio: 5.51). This means patients with dense leakage were 5.5 times more likely to develop bleeding.
  • A mASPECTS score ≤6 was linked to bleeding in initial tests but didn’t hold up in the final model—though it still provided useful context.

The dense leakage sign was especially specific: it correctly ruled out bleeding in 88% of patients without it. Only 2 of 72 patients had bleeding on the VNC scan (pre-existing), while 27 developed bleeding later—most of whom had dense leakage or low mASPECTS scores.

Why This Matters for Patients and Doctors

Iodine extravasation happens when the blood-brain barrier (BBB)—the brain’s protective “wall” against harmful substances—is damaged. Reperfusion injury (damage from restored blood flow) after thrombectomy can worsen this damage, letting contrast dye (and later, blood) leak into brain tissue.

The study’s methods solve a big problem for clinicians: they’re simple, fast, and reproducible. Unlike complex quantitative tools, mASPECTS uses the familiar ASPECTS framework (already used to assess brain damage), so radiologists don’t need new training. The dense leakage sign is even easier—a yes/no check that takes seconds.

Previous research (like a 2018 study in J Neuroimaging) found that moderate BBB damage is strongly linked to bleeding and poor outcomes. This study builds on that by giving doctors actionable tools to spot high-risk patients early.

The Bottom Line

For patients with large anterior artery strokes who’ve had successful thrombectomy:

  • A mASPECTS score ≤6 or positive dense iodine extravasation means a higher risk of bleeding.
  • These tools are based on simulated conventional CT—so they can be used even with standard single-energy CT scans (no need for dual-energy).

The study’s lead authors—Xin Gao, Qing-Tao Hui, Yu-Dan Li, Miao Peng, Dan Xu, Bin Ming, and Chun Ma from the People’s Hospital of Deyang City—note that these methods could help doctors monitor high-risk patients closer and tailor care to prevent bleeding.

This study was published in the Chinese Medical Journal in 2021.

doi.org/10.1097/CM9.0000000000001236

Was this helpful?

0 / 0